Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07468396 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Phase I Clinical Study of GLR2037 in Patients with Advanced Prostate Cancer
Trial Details
NCT Number NCT07468396
Lead Sponsor Gan & Lee Pharmaceuticals.
Conditions Prostate Cancer
Enrollment 65 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov